Ayala Pharmaceuticals Company
Ayala Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops targeted cancer therapies for people with genetically defined cancers. The company manufactures gamma secretase inhibitors as targeted treatments for cancers harboring specific notch alterations. The company was founded in 2017 and is based in Rehovot, Israel.
Headquarters:
Rehovot, Israel
Employee Number:
10-50
Founded Date:
2017
Investment Stage:
N/A
Technology:
Biotechnology, Pharmaceutical
Investor Type:
N/A
Number Of Exists:
N/A
Industry:
Personalized Medicine
Funding Status:
Early Stage Venture